Tag: Lorlatinib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Lorlatinib

US FDA Expands Approval of Pfizer's LORBRENA® as First-Line Treatment for ALK-Positive ...

Added to Collection on: 2021-03-04 00:00:00

Tags for this article:

Chemical compounds
Organic compounds
Piperidines
Breakthrough therapy
Protein kinase inhibitors
Tyrosine kinase receptors
Lung cancer
Lorlatinib
ALK inhibitor
Ceritinib
Anaplastic lymphoma kinase
ROS1
XALKORI
Pfizer Inc.
Alectinib
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
U.S. FDA Expands Approval of Pfizer's LORBRENA® as First-Line Treatment for ALK-Positive ...

Added to Collection on: 2021-03-04 14:44:28

Tags for this article:

Chemical compounds
Organic compounds
Piperidines
Breakthrough therapy
Protein kinase inhibitors
Tyrosine kinase receptors
Lung cancer
Lorlatinib
Ceritinib
ALK inhibitor
Anaplastic lymphoma kinase
ROS1
XALKORI
Pfizer Inc.
Alectinib
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
FDA Approves CDx for Lorlatinib in ALK-Positive Non–Small Cell Lung Cancer

Added to Collection on: 2021-03-09 19:07:21

Tags for this article:

Chemical compounds
Organic compounds
Chemistry
Piperidines
Breakthrough therapy
Protein kinase inhibitors
Lung cancer
Orphan drugs
ALK inhibitor
Ceritinib
Anaplastic lymphoma kinase
Lorlatinib
Roche

Click the tags to see associated articles and topics

View Article Details
Book a Demo